Lakefront Biotherapeutics (LKFT) Current Taxes (2013 - 2026)

Lakefront Biotherapeutics (LKFT) has reported Current Taxes for 13 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Current Taxes rose 420.54% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (up 420.54% YoY), while the FY2025 annual figure was $1.1 million, up 318.23% from the prior year.
• Current Taxes retreated to $1.1 million in Q1 2026 per LKFT's latest filing, from $1.1 million in the prior quarter.
• Across five years, Current Taxes topped out at $3.0 million in Q1 2022 and bottomed at $60252.6 in Q4 2023.
• Historically, Current Taxes has averaged $841687.0 across 5 years, with a median of $408000.2 in 2025.
• Annual changes were most pronounced in 2024 — Current Taxes tumbled 94.67% — and 2026, when it soared 420.54%.
• Lakefront Biotherapeutics' Current Taxes stood at $1.0 million in 2022, then slumped by 94.22% to $60252.6 in 2023, then surged by 341.61% to $266080.3 in 2024, then jumped by 318.23% to $1.1 million in 2025, then slipped by 4.05% to $1.1 million in 2026.
• Business Quant data shows LKFT's Current Taxes at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $408000.2 in Q3 2025.